Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martha Skup

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Statistics and Its Interface|June 2, 2012
Longitudinal fMRI analysis: A review of methodsMartha Skup
Statistics and Its Interface|September 28, 2011
Longitudinal fMRI analysis: A review of methodsMartha Skup
Biometrics|May 4, 2012
Multiscale adaptive marginal analysis of longitudinal neuroimaging data with time-varying covariatesMartha Skup, Hongtu Zhu, Heping Zhang
Current Medical Research and Opinion|June 3, 2017
Development of the Rheumatoid Arthritis Symptom Questionnaire (RASQ): a patient reported outcome scale for measuring symptoms of rheumatoid arthritisBenjamin Banderas, Martha Skup, Alan L Shields, et al.
Clinical Therapeutics|July 22, 2017
Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and GermanyNanxin Li, Keith A Betts, Andrew J Messali, et al.
Journal of Comparative Effectiveness Research|August 22, 2018
Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritisErin Murray, Alexandra Ellis, Yekaterina Butylkova, et al.
Clinical and Experimental Rheumatology|July 13, 2018
Short-term costs associated with non-medical switching in autoimmune conditionsAllan Gibofsky, Martha Skup, Min Yang, et al.
Advances in Therapy|June 23, 2022
Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018Yifei Liu, Martha Skup, Min Yang, et al.
Advances in Therapy|May 19, 2019
Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort StudyDaniel Aletaha, Andrew J Epstein, Martha Skup, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 21, 2009
Increased intrasubject variability in response time in youths with bipolar disorder and at-risk family membersMelissa A Brotman, Melissa H Rooney, Martha Skup, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Statistics and Its Interface|June 2, 2012
Longitudinal fMRI analysis: A review of methodsMartha Skup
Statistics and Its Interface|September 28, 2011
Longitudinal fMRI analysis: A review of methodsMartha Skup
Biometrics|May 4, 2012
Multiscale adaptive marginal analysis of longitudinal neuroimaging data with time-varying covariatesMartha Skup, Hongtu Zhu, Heping Zhang
Current Medical Research and Opinion|June 3, 2017
Development of the Rheumatoid Arthritis Symptom Questionnaire (RASQ): a patient reported outcome scale for measuring symptoms of rheumatoid arthritisBenjamin Banderas, Martha Skup, Alan L Shields, et al.
Clinical Therapeutics|July 22, 2017
Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and GermanyNanxin Li, Keith A Betts, Andrew J Messali, et al.
Journal of Comparative Effectiveness Research|August 22, 2018
Systematic review and network meta-analysis: effect of biologics on radiographic progression in rheumatoid arthritisErin Murray, Alexandra Ellis, Yekaterina Butylkova, et al.
Clinical and Experimental Rheumatology|July 13, 2018
Short-term costs associated with non-medical switching in autoimmune conditionsAllan Gibofsky, Martha Skup, Min Yang, et al.
Advances in Therapy|June 23, 2022
Discontinuation and Switchback After Non-Medical Switching from Originator Tumor Necrosis Factor Alpha (TNF) Inhibitors to Biosimilars: A Meta-Analysis of Real-World Studies from 2012 to 2018Yifei Liu, Martha Skup, Min Yang, et al.
Advances in Therapy|May 19, 2019
Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort StudyDaniel Aletaha, Andrew J Epstein, Martha Skup, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|May 21, 2009
Increased intrasubject variability in response time in youths with bipolar disorder and at-risk family membersMelissa A Brotman, Melissa H Rooney, Martha Skup, et al.
Pageof 5